IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE)

Clinical and Experimental Immunology

Volumn 122, Issue 3, 2000, Pages 471-476

  Bussolati, B ^a   Rollino, C ^b   Mariano, F ^c   Quarello, F ^b   Camussi, G ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b S GIOVANNI BOSCO HOSPITAL   (Italy)

^c CTO HOSPITAL   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

IL 10; Monocytes; Platelet activating factor; Proteinuria; Systemic lupus erythematosus

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MONOCYTES; PLATELET ACTIVATING FACTOR; PROTEINURIA;

EID: 0034529146     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01392.x     Document Type: Article

References (37)

1. Lymphocyte biology in lupus
2. Inquiry into murine and human lupus
3. In vivo production of interleukin-10 by non T cells in rheumatoid arthritis, Sjogren syndrome, and systemic lupus erythematosus: A potential mechanism of B lymphocyte hyperactivity and autoimmunity
4. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-γ-secreting cells in the peripheral blood
5. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)
6. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus
7. Interleukin-10
8. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression
9. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function
10. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells
11. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects
12. Paradoxical priming effects of IL-10 on cytokine production
13. Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leukocytes
14. Modulation of formyl peptide receptor expression by IL-10 in human monocytes and neutrophils
15. Platelet-activating factor: A phospholipid autacoid with diverse actions
16. Biology of disease: PAF molecular heterogeneity, pathobiological implications
17. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF. monocytes, polymorphonuclear neutrophils and basophils
18. Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1, tumor necrosis factor or IFN-γ
19. Platelet activating factor receptors and signal transduction
20. The intracellular retention of newly synthesized platelet-activating factor
21. Structural and (patho) physiological diversity of PAF
22. Release of platelet-activating factor in systemic lupus erythematosus
23. Increased urinary excretion of platelet activating factor in mice with lupus nephritis
24. Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus
25. Platelet-activating factor receptor blocking reduces yproteinuria and improves survival in lupus autoimmune mice
26. Derivation of the SLEDAI. A disease activity index for lupus patients
27. A rapid method of total lipid extraction and purification
28. Interactive effects of tumor necrosis factor and platelet activating factor in the pathogenesis of glomerular injury
29. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF
30. Immunoregulatory circuits and potential treatment of connective tissue diseases
31. Interleukin-10 response abnormalities in systemic lupus erythematosus
32. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10
33. Synovial fluid macrophages and blood monocytes differ in their response to IL-4
34. Differential effects of interleukins 10 and 4 on the production of interleukin-6 by blood and synovium monocytes in rheumatoid arthritis
35. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans
36. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus
37. Flaxseed: A potential treatment for lupus nephritis